Cargando…
Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
Nanovaccines, co-delivering antigen and invariant natural killer T (iNKT) cell agonists, proved to be very effective in inducing anti-tumor T cell responses due to their exceptional helper function. However, it is known that iNKT cells are not equally present in all lymphoid organs and nanoparticles...
Autores principales: | Dölen, Yusuf, Valente, Michael, Tagit, Oya, Jäger, Eliezer, Van Dinther, Eric A. W., van Riessen, N. Koen, Hruby, Martin, Gileadi, Uzi, Cerundolo, Vincenzo, Figdor, Carl G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790498/ https://www.ncbi.nlm.nih.gov/pubmed/33457086 http://dx.doi.org/10.1080/2162402X.2020.1738813 |
Ejemplares similares
-
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses
por: Dölen, Yusuf, et al.
Publicado: (2021) -
Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
por: Jukes, John‐Paul, et al.
Publicado: (2016) -
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
por: Dölen, Yusuf, et al.
Publicado: (2015) -
Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles
por: Operti, Maria Camilla, et al.
Publicado: (2019) -
Förster Resonance Energy Transfer-Based Stability
Assessment of PLGA Nanoparticles in Vitro and in Vivo
por: Swider, Edyta, et al.
Publicado: (2019)